Medicine
Avycaz 0.5 g/2 g powder for injection
Avycaz 0.5 g/2 g powder for injection is a prescription medicine containing Avibactam and Ceftazidime for intravenous use, marketed by Allergan, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in carton until time of use. Storage conditions for constituted and…
Key facts
- Active ingredient (INN)
- Avibactam and Ceftazidime
- Brand
- Avycaz
- Strength
- 0.5 g/2 g
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 10 vials
- Marketing authorisation holder
- Allergan
- Manufacturer
- Allergan
- Origin register
- US FDA, United States
- Storage
- Store in carton until time of use. Storage conditions for constituted and diluted solutions of AVYCAZ for injection are described in another section of labeling.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DD52 Avibactam and Ceftazidime
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 December 2014
- Identifiers
- RxCUI 1603840, 1603845DailyMed set ID d9c2803f-dc9c-4b19-b4a3-8303bc8c15fdNDC 0456-2700Application NDA206494
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 1 powder, for solution in 1 vial, single-dose | 0456-2700-10 | Allergan | 26 December 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Avibactam and Ceftazidime is a fixed-dose combination of a cephalosporin antibacterial and a beta lactamase inhibitor indicated for the treatment of infections caused by designated susceptible Gram-negative microorganisms in adult, among other approved uses. MedsAcross supplies Avibactam and Ceftazidime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Avibactam and CeftazidimeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- AVYCAZ prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Zavicefta: European public assessment report (EPAR) · European Medicines Agency
Need Avycaz 0.5 g/2 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.